SecurityBRKR / Bruker Corp.
InstitutionBridgewater Associates, LP
ManagerRay Dalio, Bob Prince
Shares19,029
Value $ 553,000

Bridgewater Associates, LP reports 38.89% decrease in ownership of BRKR / Bruker Corp.

August 13, 2018 - Bridgewater Associates, LP has filed a 13F-HR form disclosing ownership of 19,029 shares of Bruker Corp. (NASDAQ:BRKR) with total holdings valued at $553,000 USD as of June 30, 2018. Bridgewater Associates, LP had filed a previous 13F-HR on May 15, 2018 disclosing 31,137 shares of Bruker Corp. at a value of $932,000 USD. This represents a change in shares of -38.89 percent and a change in value of -40.67 percent during the quarter.

Other investors with positions similar to Bridgewater Associates, LP include BLB&B Advisors, LLC, Cantab Capital Partners LLP, State Of Wisconsin Investment Board, Squarepoint Ops LLC, Brinker Capital Inc, and Spring Creek Capital Llc.

Bruker Corp. has declared a standard industrial code (sic) of 3826 which is the "Laboratory Analytical Instruments" industry. Bridgewater Associates, LP's top industries are "Printing, Publishing, And Allied Industries" (sic 27), "Rubber And Miscellaneous Plastics Products" (sic 30), and "Stone, Clay, Glass, And Concrete Products" (sic 32).

Bridgewater Associates, LP reports 38.89% decrease in  ownership of BRKR / Bruker Corp.

13F Filings

The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.

In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Effective
Date
Form Security Class CUSIP Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2018-06-30 13F-HR BRUKER COM 116794108 29.50 19,029 -38.89 553 -40.67 -357 -22 -2.34
2018-03-31 13F-HR BRUKER COM 116794108 31,137 932 932 0
2015-12-31 13F-HR BRUKER COM 116794108 0 -100.00 0 -100.00 -424 0
2015-09-30 13F-HR BRUKER COM 116794108 25,806 424

Related SEC Filings

BRKR / Bruker Corp. / PRICE T ROWE ASSOCIATES INC /MD/ - 3G/A (Passive Investment)

2018-02-14 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 8) BRUKER CORP (Name of Issuer) COMMON STOCK (Title of Class of Securities) 116794108 (CUSIP NUMBER) December 31, 2017 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is filed: [x] Rule 13d - 1(b) Rule 13d - 1(c) Rule 13d - 1(d) 1.

BRKR / Bruker Corp. / PRICE T ROWE ASSOCIATES INC /MD/ - 3G/A (Passive Investment)

2018-02-14 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 8) BRUKER CORP (Name of Issuer) COMMON STOCK (Title of Class of Securities) 116794108 (CUSIP NUMBER) December 31, 2017 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is filed: [x] Rule 13d - 1(b) Rule 13d - 1(c) Rule 13d - 1(d) 1.

BRKR / Bruker Corp. / VANGUARD GROUP INC - 3G/A (Passive Investment)

2018-02-08 sec.gov
brukercorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 1 )*       Name of issuer:  Bruker Corp     Title of Class of Securities:  Common Stock     CUSIP Number:  116794108     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   (X) Rule 13d-1(b)   

BRKR / Bruker Corp. / VANGUARD GROUP INC - 3G/A (Passive Investment)

2018-02-08 sec.gov
brukercorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 1 )*       Name of issuer:  Bruker Corp     Title of Class of Securities:  Common Stock     CUSIP Number:  116794108     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   (X) Rule 13d-1(b)   

BRKR / Bruker Corp. / LAUKIEN JOERG C - SC 13G/A (Passive Investment)

2018-02-02 sec.gov
    UNITED STATES     SECURITIES AND EXCHANGE COMMISSION     Washington, D.C. 20549         SCHEDULE 13G (Rule 13d-102)   INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2   Under the Securities Exchange Act of 1934 (Amendment No. 19)*   Bruker Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 116794108 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Stat

Related News Stories

Top Analyst Upgrades and Downgrades: AMD, Caterpillar, NRG, Nvidia, P&G, Square, Red Hat, Transocean, Viacom, Wisdom Tree and More

2018-09-20 247wallst
Stocks were flat in the early morning hours on Thursday, but futures turned higher on all three major U.S. equity indexes. The markets are back to challenging their highs as well, but not necessarily in international and emerging markets. As many investors have seen lower upside from buying on market pullbacks than in prior years, they have to consider how they want to have their investments positioned for the rest of 2018 and as 2019 approaches. (28-0)

Bruker to Expand Molecular Diagnostics Arm With Hain Buyout

2018-08-27 zacks
Bruker Corporation (BRKR - Free Report) recently announced its decision to acquire Germany-based Hain Lifesciences GmbH, a developer, manufacturer and distributor of molecular diagnostics (MDx) solutions. The acquisition is expected to boost Bruker’s microbiology and diagnostics business.

Bruker Corporation 2018 Q2 - Results - Earnings Call Slides

2018-08-20 seekingalpha
The following slide deck was published by Bruker Corporation in conjunction with their 2018 Q2 earnings call.

Sleepy Summer? Not For All Stocks. Check These Out

2018-08-20 seekingalpha
Market “leaders” have well-behaved prices, but there are quality outlier-priced stocks in several groups. We reveal some of them here with quick-survey methods (reward~risk maps). (2-2)

Bruker (BRKR) Q2 Earnings Meet Estimates, Margins Expand

2018-08-06 zacks
Bruker Corporation (BRKR - Free Report) reported adjusted earnings per share (EPS) of 25 cents in the second quarter of 2018, up 8.7% from the year-ago figure. Adjusted EPS remained in line with the Zacks Consensus Estimate. (2-0)



CUSIP: 116794108